
浏览全部资源
扫码关注微信
1.内蒙古医科大学鄂尔多斯临床医学院/鄂尔多斯市中心医院放射科,内蒙古 鄂尔多斯 017000
2.内蒙古医科大学鄂尔多斯临床医学院/鄂尔多斯市中心医院CT-MRI室,内蒙古 鄂尔多斯 017000
徐彦东,E-mail:xuyandong@126.com
纸质出版日期:2023-08-25,
收稿日期:2022-09-14,
扫 描 看 全 文
李香霞,徐彦东.Revolution CT多模式重建对肝门部胆管癌术前分期及手术方式评估的研究[J].局解手术学杂志,2023,32(08):712-715.
LI Xiang-xia,XU Yan-dong.Evaluation of preoperative staging and surgical methods of hilar cholangiocarcinoma by Revolution CT multimodal reconstruction[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(08):712-715.
李香霞,徐彦东.Revolution CT多模式重建对肝门部胆管癌术前分期及手术方式评估的研究[J].局解手术学杂志,2023,32(08):712-715. DOI: 10.11659/jjssx.09E022072.
LI Xiang-xia,XU Yan-dong.Evaluation of preoperative staging and surgical methods of hilar cholangiocarcinoma by Revolution CT multimodal reconstruction[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(08):712-715. DOI: 10.11659/jjssx.09E022072.
目的
2
探究Revolution CT多模式重建对肝门部胆管癌(HCCA)术前分期及手术方式的评估价值。
方法
2
选取鄂尔多斯市中心医院89例HCCA患者,术前均行Revolution CT多模式重建,以手术病理诊断结果为金标准,分析Revolution CT多模式重建诊断HCCA肿瘤类型、肝叶萎缩、肝动脉侵犯、门静脉侵犯、淋巴结转移、Bismuth-Corlette分型、临床分期及手术可切除性的价值。
结果
2
Revolution CT多模式重建诊断的HCCA肿瘤类型与手术病理诊断结果一致,诊断准确率为100%。Revolution CT多模式重建诊断HCCA肝叶萎缩、肝动脉侵犯、门静脉侵犯、淋巴结转移结果与手术病理诊断结果比较,差异无统计学意义(
P
>
0.05)。Revolution CT多模式重建诊断HCCA Bismuth-Corlette分型与手术病理诊断的
Kappa
值为0.886(95%
CI
:0.781~0.992),诊断符合率为91.01%(
P
<
0.05)。Revolution CT多模式重建诊断HCCA临床分期与手术病理诊断的
Kappa
值为0.891(95%
CI
:0.766~1.016),诊断符合率为92.13%(
P
<
0.05)。Revolution CT多模式重建诊断HCCA手术可切除性与手术病理诊断的
Kappa
值为0.887(95%
CI
:0.681~1.094),诊断符合率为94.38%(
P
<
0.05)。
结论
2
Revolution CT多模式重建能准确判断术前HCCA肿瘤类型、Bismuth-Corlette分型和临床分期,可为临床制定个性化手术方案提供可靠依据。
Objective
2
To explore the evaluation value of preoperative staging and surgical methods of hilar cholangiocarcinoma (HCCA) by Revolution CT multimodal reconstruction.
Methods
2
A total of 89 patients with HCCA in Erdos Central Hospital were selected and all of them underwent Revolution CT multimodal reconstruction before surgery.The value of Revolution CT multimodal reconstruction in diagnosing HCCA tumor type, liver lobe atrophy, hepatic artery invasion, portal vein invasion, lymph node metastasis, Bismuth-Corlette classification, clinical staging and surgical resectability was analyzed by taking the surgical pathological diagnosis results as the gold standard.
Results
2
The HCCA tumor type diagnosed by Revolution CT multimodal reconstruction was consistent with the results of surgical pathological diagnosis, with the diagnostic accuracy rate of 100%. There was no significant difference between the results of Revolution CT multimodal reconstruction in the diagnosis of hepatic lobe atrophy, hepatic artery invasion, portal vein invasion or lymph node metastasis of HCCA compared with surgical pathological diagnosis (
P
>
0.05). The
Kappa
value between Revolution CT multimodal reconstruction and surgical pathological diagnosis in the diagnosis of HCCA Bismuth-Corlette classification was 0.886 (95%
CI
: 0.781 to 0.992), and the diagnostic coincidence rate was 91.01% (
P
<
0.05). The
Kappa
value of Revolution CT multimodal reconstruction and surgical pathological diagnosis in the diagnosis of HCCA clinical staging was 0.891 (95%
CI
:0.766 to 1.016), with the diagnostic coincidence rate of 92.13% (
P
<
0.05).The
Kappa
value of Revolution CT multimodal reconstruction and surgical pathological diagnosis in the diagnosis of HCCA surgical resectability was 0.887 (95%
CI
: 0.681 to 1.094), with the diagnostic coincidence rate of 94.38% (
P
<
0.05).
Conclusion
2
Revolution CT multimodal reconstruction can accurately determine the preoperative tumor type, Bismuth-Corlette classification and clinical staging of HCCA, which can provide a reliable reference for the development of personalized surgical plans in clinic.
肝门部胆管癌CT多模式重建临床分期肿瘤分型
hilar cholangiocarcinomaCT multimodal reconstructionclinical stagingtumor type
Soares KC,Jarnagin WR.The landmark series:hilar cholangiocarcinoma[J].Ann Surg Oncol,2021,28(8):4158-4170.doi:10.1245/s10434-021-09871-6http://dx.doi.org/10.1245/s10434-021-09871-6.
Inchingolo R,Acquafredda F,Ferraro V,et al.Non-surgical treatment of hilar cholangiocarcinoma[J].World J Gastrointest Oncol,2021,13(11):1696-1708.doi:10.4251/wjgo.v13.i11.1696http://dx.doi.org/10.4251/wjgo.v13.i11.1696.
Lauterio A,De Carlis R,Centonze L,et al.Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma[J].Cancers (Basel),2021,13(15):3657.doi:10.3390/cancers13153657http://dx.doi.org/10.3390/cancers13153657.
武盼盼,徐蒙莱,褚建华,等.应用CT三维重建技术判断肝门部胆管癌可切除性价值分析[J].实用肝脏病杂志,2020,23(6):889-892.doi:10.3969/j.issn.1672-5069.2020.06.033http://dx.doi.org/10.3969/j.issn.1672-5069.2020.06.033.
Zhou Q,Dong G,Zhu Q,et al.Modification and comparison of CT criteria in the preoperative assessment of hepatic arterial invasion by hilar cholangiocarcinoma[J].Abdom Radiol (NY),2021,46(5):1922-1930.doi:10.1007/s00261-020-02849-0http://dx.doi.org/10.1007/s00261-020-02849-0.
Zhou Q,Guan Y,Mao L,et al.Modification and establishment of CT criteria in preoperative assessment of portal venous invasion by hilar cholangiocarcinoma[J].HPB (Oxford),2018,20(12):1163-1171.doi:10.1016/j.hpb.2018.05.013http://dx.doi.org/10.1016/j.hpb.2018.05.013.
何冠勇,成官迅,范秀松,等.Revolution CT能谱单能量及自适应统计迭代重建联合优化门静脉图像质量[J].实用医技杂志,2019,26(5):558-559.doi:10.19522/j.cnki.1671-5098.2019.05.009http://dx.doi.org/10.19522/j.cnki.1671-5098.2019.05.009.
Thüring J,Rippel O,Haarburger C,et al.Multiphase CT-based prediction of Child-Pugh classification:a machine learning approach[J].Eur Radiol Exp,2020,4(1):20.doi:10.1186/s41747-020-00148-3http://dx.doi.org/10.1186/s41747-020-00148-3.
中国抗癌协会.肝门部胆管癌规范化诊治专家共识(2015)[J].中华肝胆外科杂志,2015,21(8):505-511.doi:10.3760/cma.j.issn.1007-8118.2015.08.001http://dx.doi.org/10.3760/cma.j.issn.1007-8118.2015.08.001.
Passeri MJ,Baimas-George MR,Sulzer JK,et al.Prognostic impact of the Bismuth-Corlette classification:higher rates of local unresectability in stage Ⅲb hilar cholangiocarcinoma[J].Hepatobiliary Pancreat Dis Int,2020,19(2):157-162.doi:10.1016/j.hbpd.2020.02.001http://dx.doi.org/10.1016/j.hbpd.2020.02.001.
蔡秀军.美国癌症联合会(AJCC)癌症分期手册第8版“肝门部胆管癌”部分更新解读[J].临床外科杂志,2018,26(1):10-12.doi:10.3969/j.issn.1005-6483.2018.01.003http://dx.doi.org/10.3969/j.issn.1005-6483.2018.01.003.
Mansour JC,Aloia TA,Crane CH,et al.Hilar cholangiocarcinoma:expert consensus statement[J].HPB (Oxford),2015,17(8):691-699.doi:10.1111/hpb.12450http://dx.doi.org/10.1111/hpb.12450.
耿云平,任悠悠,李真真,等.CT三维重建在肝门部胆管癌切除术前评估中的价值[J].中国现代普通外科进展,2022,25(6):467-469.doi:10.3969/j.issn.1009-9905.2022.06.013http://dx.doi.org/10.3969/j.issn.1009-9905.2022.06.013.
丁聪,田为中,梁雯丽,等.Revolution CT在显示食管癌病变的最佳单能量分析[J].医学影像学杂志,2020,30(5):889-892.
唐卫东,邓杰文,姜超,等.64排螺旋CT联合多模式重建图像在肝门部胆管癌可切除性术前评估中的应用[J].分子影像学杂志,2020,43(4):680-683.doi:10.12122/j.issn.1674-4500.2020.04.28http://dx.doi.org/10.12122/j.issn.1674-4500.2020.04.28.
Ku D,Tang R,Pang T,et al.Survival outcomes of hepatic resections in Bismuth-Corlette type Ⅳ cholangiocarcinoma[J].ANZ J Surg,2020,90(9):1604-1614.doi:10.1111/ans.15531http://dx.doi.org/10.1111/ans.15531.
Fan S,Yang L,Cao X,et al.The "Hand as Foot" teaching method in Bismuth-Corlette classification of hilar cholangiocarcinoma[J].Asian J Surg,2022,45(7):1459-1460.doi:10.1016/j.asjsur.2022.02.049http://dx.doi.org/10.1016/j.asjsur.2022.02.049.
林科灿,曾永毅,黎蕴通,等.三维重建虚拟手术规划在肝门部胆管癌手术中的应用价值[J].中华消化外科杂志,2018,17(4):383-388.doi:10.3760/cma.j.issn.1673-9752.2018.04.012http://dx.doi.org/10.3760/cma.j.issn.1673-9752.2018.04.012.
0
浏览量
2
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621